MyAmyloidosisTeam

Great question! Amvuttra (vutrisiran) and Vyndamax (tafamidis) are both used in ATTR amyloidosis treatment, but they work in very different ways.

Amvuttra belongs to a class called RNA interference (RNAi) therapies. It works by blocking the production of abnormal TTR protein before it can build up and cause harm. Think of Show Full Answer

Great question! Amvuttra (vutrisiran) and Vyndamax (tafamidis) are both used in ATTR amyloidosis treatment, but they work in very different ways.

Amvuttra belongs to a class called RNA interference (RNAi) therapies. It works by blocking the production of abnormal TTR protein before it can build up and cause harm. Think of it like turning off a faucet before a flood starts. It is approved for:

- Polyneuropathy (nerve damage) from hereditary ATTR amyloidosis
- Cardiomyopathy (heart muscle disease) from both wild-type and hereditary ATTR amyloidosis

It is given as an injection under the skin once every three months by a healthcare professional. Vyndamax works differently — instead of stopping TTR protein production, it stabilizes the TTR protein so it is less likely to misfold and form amyloid deposits. It is approved specifically for cardiomyopathy in ATTR amyloidosis and is taken orally (as a pill).

A key caution with Vyndamax: allergic reactions are possible. Seek immediate medical attention if you experience:

- Trouble swallowing
- Hives or itchy skin rashes
- Chest tightness
- Fast heartbeat

The best choice between these two depends on your specific type of ATTR amyloidosis, symptoms, and overall health. Always discuss with your specialist to find the right fit for you.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Amvuttra

8 Amyloidosis Treatments and Their Side Effects